114 related articles for article (PubMed ID: 2017754)
1. Effects of bisbenzylisoquinoline alkaloids on alveolar macrophages: correlation between binding affinity, inhibitory potency, and antifibrotic potential.
Castranova V; Kang JH; Ma JK; Mo CG; Malanga CJ; Moore MD; Schwegler-Berry D; Ma JY
Toxicol Appl Pharmacol; 1991 Apr; 108(2):242-52. PubMed ID: 2017754
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of respiratory burst activity in alveolar macrophages by bisbenzylisoquinoline alkaloids: characterization of drug-cell interaction.
Ma JY; Barger MW; Ma JK; Castranova V
Exp Lung Res; 1992; 18(6):829-43. PubMed ID: 1361431
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory action of tetrandrine on macrophage production of interleukin-1 (IL-1)-like activity and thymocyte proliferation.
Kang JH; Lewis DM; Castranova V; Rojanasakul Y; Banks DE; Ma JY; Ma JK
Exp Lung Res; 1992; 18(5):715-29. PubMed ID: 1396414
[TBL] [Abstract][Full Text] [Related]
4. Binding of bisbenzylisoquinoline alkaloids to phosphatidylcholine vesicles and alveolar macrophages: relationship between binding affinity and antifibrogenic potential of these drugs.
Ma JK; Mo CG; Malanga CJ; Ma JY; Castranova V
Exp Lung Res; 1991; 17(6):1061-77. PubMed ID: 1663032
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of stimulant-induced activation of phagocytic cells with tetrandrine.
Castranova V; Kang JH; Moore MD; Pailes WH; Frazer DG; Schwegler-Berry D
J Leukoc Biol; 1991 Oct; 50(4):412-22. PubMed ID: 1655939
[TBL] [Abstract][Full Text] [Related]
6. Tetrandrine inhibits signal-induced NF-kappa B activation in rat alveolar macrophages.
Chen F; Sun S; Kuhn DC; Lu Y; Gaydos LJ; Shi X; Demers LM
Biochem Biophys Res Commun; 1997 Feb; 231(1):99-102. PubMed ID: 9070227
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of bisbenzylisoquinoline alkaloids on nitric oxide production in activated macrophages.
Kondo Y; Takano F; Hojo H
Biochem Pharmacol; 1993 Dec; 46(11):1887-92. PubMed ID: 7505581
[TBL] [Abstract][Full Text] [Related]
8. [Study of alveolar macrophages stimulated with zymosan in vivo using fluorescent probes].
Shishkina LN; Kolosova NG; Maianskiĭ DN
Biull Eksp Biol Med; 1986 Sep; 102(9):319-21. PubMed ID: 3756335
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity to macrophages of tetrandrine, an antisilicosis alkaloid, accompanied by an overproduction of prostaglandins.
Pang L; Hoult JR
Biochem Pharmacol; 1997 Mar; 53(6):773-82. PubMed ID: 9113098
[TBL] [Abstract][Full Text] [Related]
10. Differential dependence on protein kinase C of arachidonic acid metabolism stimulated by hydrogen peroxide and by zymosan in the alveolar macrophage.
Sporn PH; Marshall TM; Peters-Golden M
Biochim Biophys Acta; 1990 Nov; 1047(2):187-91. PubMed ID: 2123406
[TBL] [Abstract][Full Text] [Related]
11. Alterations in alveolar type II cell metabolism induced by tetrandrine and other alkaloids.
Miles PR; Bowman L; Ma JK; Ma JY
Toxicol Appl Pharmacol; 1993 Mar; 119(1):142-9. PubMed ID: 8470118
[TBL] [Abstract][Full Text] [Related]
12. [Synergistic activation of rat alveolar macrophages by cepharanthine and OK-432].
Morioka S; Ono M; Tanaka N; Orita K
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1470-5. PubMed ID: 4015121
[TBL] [Abstract][Full Text] [Related]
13. Modification of alveolar macrophage function with bis-basic ethers of fluorene and fluoren-9-substituted derivatives.
Ma JY; Cheng YH; Barger MW; Xin WF; Lewis DM; Castranova V; Ma JK
Exp Lung Res; 1995; 21(5):771-90. PubMed ID: 8556993
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin synthesis and release by subpopulations of rat alveolar macrophages.
Chandler DB; Fulmer JD
J Immunol; 1987 Aug; 139(3):893-8. PubMed ID: 3110287
[TBL] [Abstract][Full Text] [Related]
15. Generation of oxygen radicals and mechanisms of injury prevention.
Castranova V
Environ Health Perspect; 1994 Dec; 102 Suppl 10(Suppl 10):65-8. PubMed ID: 7705309
[TBL] [Abstract][Full Text] [Related]
16. Complement modulatory activity of bisbenzylisoquinoline alkaloids isolated from Isopyrum thalictroides--II. Influence on C3-9 reactions in vitro and antiinflammatory effect in vivo.
Ivanovska N; Hristova M; Philipov S
Int J Immunopharmacol; 1999 May; 21(5):337-47. PubMed ID: 10408630
[TBL] [Abstract][Full Text] [Related]
17. Studies on the inhibitory effect of tetrandrine on silica-induced fibrogenesis in vitro.
Li YR; Cai GP; Liu LF; Chen NM; Li CL
Biomed Environ Sci; 1988 Aug; 1(2):125-9. PubMed ID: 2855825
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic bisbenzylisoquinoline alkaloids from Stephania epigaea.
Lv JJ; Xu M; Wang D; Zhu HT; Yang CR; Wang YF; Li Y; Zhang YJ
J Nat Prod; 2013 May; 76(5):926-32. PubMed ID: 23621840
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives.
Qian JQ
Acta Pharmacol Sin; 2002 Dec; 23(12):1086-92. PubMed ID: 12466045
[TBL] [Abstract][Full Text] [Related]
20. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
Hsu YC; Chiu YT; Cheng CC; Wu CF; Lin YL; Huang YT
J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
